SEMAGLUTIDE/B12 0.6 MG/500 MCG/ML (2 ML)
- An injectable semaglutide + vitamin B12 treatment option for weight management through provider-guided care.
- Treatment requires licensed provider review and a prescription when clinically appropriate.
Semaglutide is a GLP-1 receptor agonist used in certain weight-management treatment plans. This formulation also contains vitamin B12. Your licensed provider will determine whether this treatment is appropriate based on your health information and clinical needs. The safety and effectiveness of combining semaglutide with vitamin B12 have not been established by the FDA.
Use this injectable treatment exactly as prescribed by your healthcare provider. Your provider or dispensing pharmacy should provide specific instructions for the prescribed dose, injection technique, storage, and handling. Do not change the prescribed dose or injection frequency on your own.
Semaglutide may cause side effects, including gastrointestinal symptoms such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort. Your provider should review your medical history, medications, potential interactions, and other safety considerations before treatment. Compounded injectable semaglutide can also involve dosing risks when concentrations or measurement instructions vary, so follow the exact instructions provided with your medication.
Your treatment is guided by a licensed healthcare provider who determines whether this medication is clinically appropriate for you and provides instructions for its use. Your provider can review your response to treatment, address concerns, and determine whether your treatment plan should be continued or adjusted.
Start Your Semaglutide
+ B12 Care Journey
A simple, provider-guided process to determine whether semaglutide + B12 treatment may be appropriate for you.
- 1Get Started
Provide the information needed for a licensed healthcare provider to review your treatment needs.
Quick online process
- 2Provider Review
A licensed provider reviews your information and determines whether this treatment is clinically appropriate.
Prescription required
- 3Receive Your Treatment
If prescribed, your medication is prepared and delivered with instructions for use.
Discreet delivery available
- 4Continue Your Care
Follow your prescribed treatment plan and receive ongoing provider guidance as needed.
Provider-guided care
Know More Before
Starting Treatment
Review important information about this injectable formulation, the semaglutide + B12 combination, safe use, and ongoing provider-guided care.
- What to Know About the B12 Component
- Injection & Dose Measurement
- Medication & Health Considerations
- When to Contact Your Provider
- Reviewing Treatment Over Time
Semaglutide/B12 treatment requires evaluation and a prescription from a licensed healthcare provider. This formulation may be compounded and is not FDA-approved. The safety and effectiveness of combining semaglutide with vitamin B12 have not been established by the FDA. Follow the dosing and administration instructions provided with your medication and contact your healthcare provider with questions or concerns.
Explore More
Treatment Options
Review other weight-management options available through provider-guided care and find the approach that may fit your needs.
SEMAGLUTIDE ODT 10MG
Starts atFrom $99/moPrescription requiredSEMAGLUTIDE/B12 0.6 MG/ 500 MCG/ML (2 ML) (you’re viewing this)
Starts atFrom $99/moPrescription requiredOral Tirzepatide 5mg
Starts atFrom $99/moPrescription requiredTirzepatide + B12 Injection 5mg/0.5mg/mL
Starts atFrom $99/moPrescription required
Your Semaglutide + B12
Treatment Plan
Your provider determines the appropriate treatment approach, dosage, and administration instructions based on your individual health needs and response to treatment.
If prescribed, your provider will give you specific instructions for starting treatment, including how and when to use your medication.
Use your medication exactly as prescribed and follow the instructions provided by your healthcare provider and dispensing pharmacy.
Your provider may review your response, treatment experience, and health needs to determine the appropriate next step in your care.
Treatment plans, dosage, and ongoing care vary by individual. Do not change your dose or treatment schedule without guidance from your healthcare provider. For compounded injectable semaglutide, follow the exact measurement and administration instructions provided with your prescription.
Frequently Asked Questions
SEMAGLUTIDE/B12 0.6 MG/500 MCG/ML is an injectable formulation containing semaglutide and vitamin B12. It may be considered as part of a provider-guided weight-management treatment plan when clinically appropriate.
This formulation combines semaglutide with vitamin B12. However, the FDA states that the safety and effectiveness of combining semaglutide with vitamin B12 have not been established, so your provider should determine whether this formulation is appropriate for you.
This compounded semaglutide + B12 formulation is not FDA-approved. Compounded drugs are not reviewed by the FDA for safety, effectiveness, or quality before marketing. Your provider should determine whether a compounded treatment is medically appropriate for your individual needs.
Yes. This treatment requires evaluation by a licensed healthcare provider and a prescription when the provider determines that treatment is clinically appropriate for you.
Semaglutide may cause gastrointestinal side effects such as nausea, vomiting, diarrhea, constipation, or abdominal discomfort. Your provider should review potential risks, your medical history, and other medications before treatment. Seek medical advice if you experience concerning or severe symptoms.
SEMAGLUTIDE/B12 treatment requires evaluation and a prescription from a licensed healthcare provider. Treatment suitability, dosage, administration instructions, and ongoing care are determined based on individual health needs. This compounded formulation is not FDA-approved, and the safety and effectiveness of combining semaglutide with vitamin B12 have not been established by the FDA.